title: Urotensin II inhibits the proliferation but not the differentiation of cardiac side population cells.
abstract: Urotensin II (UII) induces the development of cardiac remodeling and atherosclerosis by promoting hypertrophy of cardiomyocytes and mitogenesis of fibroblasts and vascular smooth muscle cells. But its effect on cardiac side population cells (CSPs), one of somatic stem cells, is unclear. The present study examined the influences of UII on the differentiation and proliferation of CSPs. CSPs were isolated from neonatal rat hearts by fluorescence-activated cell sorting (FACS) and cultured with or without the presence of UII (10(-8), 10(-7), 10(-6)mol/l). The expressions of α-cardiac myosin heavy chain (α-MHC), α-smooth muscle actin (SMA) and Von Willebrand factor (vWF) mRNAs and proteins were analyzed by reverse transcriptional PCR (RT-PCR) and immunofluorescence to evaluate the differentiation of CSPs into cardiomyocytes, smooth muscle cells and endothelial cells, respectively. The proliferation of CSPs was assessed by Luminescent Cell Viability Assay. The influence of UII on the proliferation of CSPs in vivo was also evaluated by FACS. Our results revealed that UII did inhibit the proliferation of CSPs through up-regulation of phosphorylated c-Jun N-terminal protein kinase (JNK), although it didn't affect the differentiation of cultured CSPs. Experiments in vivo also showed that UII reduced the number of CSPs in mice compared with control group. These data indicate that UII reduces the number of CSPs by inhibiting the proliferation of CSPs possibly through increase of JNK phosphorylation.
authors.affiliation: Institutes of Biomedical Sciences, Fudan University, 138 Yixueyuan Road, Shanghai 200032, China.
authors.forename: Hui
authors.initials: H
authors.lastname: Gong
authors.forename: Hong
authors.initials: H
authors.lastname: Ma
authors.forename: Meilan
authors.initials: M
authors.lastname: Liu
authors.forename: Bojiang
authors.initials: B
authors.lastname: Zhou
authors.forename: Guoping
authors.initials: G
authors.lastname: Zhang
authors.forename: Zhidan
authors.initials: Z
authors.lastname: Chen
authors.forename: Guoliang
authors.initials: G
authors.lastname: Jiang
authors.forename: Yuan
authors.initials: Y
authors.lastname: Yan
authors.forename: Chunjie
authors.initials: C
authors.lastname: Yang
authors.forename: Masato
authors.initials: M
authors.lastname: Kanda
authors.forename: Jian
authors.initials: J
authors.lastname: Wu
authors.forename: Jie
authors.initials: J
authors.lastname: Yuan
authors.forename: Lei
authors.initials: L
authors.lastname: Li
authors.forename: Toshio
authors.initials: T
authors.lastname: Nagai
authors.forename: Issei
authors.initials: I
authors.lastname: Komuro
authors.forename: Junbo
authors.initials: J
authors.lastname: Ge
authors.forename: Yunzeng
authors.initials: Y
authors.lastname: Zou
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D015153:Blotting, Western; D002454:Cell Differentiation / Q000187:drug effects*; D049109:Cell Proliferation / Q000187:drug effects*; D002478:Cells, Cultured; D005434:Flow Cytometry; D005455:Fluorescent Antibody Technique; D008297:Male; D051379:Mice; D032383:Myocytes, Cardiac / Q000166:cytology* / Q000187:drug effects*; D051381:Rats; D058985:Side-Population Cells / Q000166:cytology* / Q000187:drug effects*; D014579:Urotensins / Q000494:pharmacology*
chemical_list: D014579:Urotensins; C029677:urotensin II